EVH (Evolent Health) Short-Term Debt: $0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EVH Evolent Health Inc EVH
66 GF Score
Price $5.87
GF Value $11.32
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Evolent Health Short-Term Debt?

Evolent Health EVH -5.17% 66 Short-Term Debt is $0 Mil as of Mar. 2026. GuruFocus rates EVH with a GF Score™ of 66/100 and a GF Value™ of $11.32 (Possible Value Trap). The stock has 7 warning signs investors should review.

Evolent Health's Short-Term Debt for the quarter that ended in Mar. 2026 was $0 Mil.

Evolent Health's quarterly Short-Term Debt declined from Sep. 2025 ($5 Mil) to Dec. 2025 ($0 Mil) but then stayed the same from Dec. 2025 ($0 Mil) to Mar. 2026 ($0 Mil).

Evolent Health's annual Short-Term Debt increased from Dec. 2023 ($0 Mil) to Dec. 2024 ($171 Mil) but then declined from Dec. 2024 ($171 Mil) to Dec. 2025 ($0 Mil).

Evolent Health Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Evolent Health Short-Term Debt Related Terms

Evolent Health Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Evolent Health's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolent Health Short-Term Debt Chart

Evolent Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 171.47 0.00

Evolent Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.79 172.12 5.12 0.00 0.00
EVH
66GF Score
Evolent Health Inc EVH
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0 Mil mean?
Evolent Health (EVH) has a Short-Term Debt of $0 Mil as of Mar. 2026.
Is Evolent Health's Short-Term Debt too high?
Evolent Health's current Short-Term Debt is $0 Mil. Overall, Evolent Health has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's Short-Term Debt compare to PHR and CTEV?
Evolent Health's Short-Term Debt of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Evolent Health's current Short-Term Debt is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $11.32, compared to a current price of $5.87 — trading 48.1% below its estimated fair value. The current Short-Term Debt is $0 Mil. Evolent Health's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Evolent Health (EVH), the current Short-Term Debt is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evolent Health (EVH) Overvalued in 2026?

Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued. The current stock price of $5.87 is trading 48.1% below its estimated GF Value™ of $11.32. GuruFocus considers Evolent Health to be Possible Value Trap.

Key valuation signals for EVH:

  • Short-Term Debt: $0 Mil
  • GF Value™: $11.32 vs. price of $5.87 (48.1% below fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evolent Health Business Description

Other Exchanges 9EH:Germany
Address 1812 North Moore Street, Suite 1705, Arlington, VA, USA, 22209
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
66GF Score

Get the complete analysis for EVH

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.87
Price
$11.32
GF Value